Rectal cancer with proficient mismatch repair (pMMR) research hub

OV-PRIME-R (Oncolytic Virotherapy to enhance PReoperative IMmunotherapy Efficacy in patients with proficient mismatch repair (pMMR) Rectal cancer

This study is testing a new virus-based treatment for rectal cancer where the cancer cells can fix their DNA. It's an early-stage trial trying to see if this new treatment can make existing immune therapies work better before surgery.